Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA TrialMichael C. Kreißl, Martin Schlumberger, Raffaella Colzani et al.|Journal of Clinical Oncology|2020Cited by 61